½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1394975

ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå : Á¦Ç°º°, Æ÷Åͺô¸®Æ¼º°, ¹æ½Äº°, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2023-2032³â)

Fetal Monitoring Market - By Product, By Portability, By Method, By End-use - Global Forecast, 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 589 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2023-2032³â CAGR 6.7%¸¦ ±â·ÏÇÕ´Ï´Ù.

Á¤ºÎ ±â°üÀº ÀÇ·á Àü¹®°¡¸¦ ±³À°ÇÏ´Â °ÍÀ» ¿ì¼±¼øÀ§·Î »ï°í ÅÂ¾Æ ¸ð´ÏÅ͸µ¿¡¼­ ±â¼ú Çõ½ÅÀÇ Áß¿äÇÑ Çʿ伺À» ÀÌÇØÇϱ⸦ Èñ¸ÁÇÕ´Ï´Ù.

¿¹¸¦ µé¾î 2023³â 9¿ù ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)Àº ÅÂ¾Æ Áø´Ü ¹× ¸ð´ÏÅ͸µ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ¹ÌÈ­ 200¸¸ ´Þ·¯ÀÇ »ó±ÝÀ» ³»°É°í °ø¸ðÀüÀ» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ½Ãµµ´Â ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­ žÆÀÇ °Ç°­ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ °ÍÀ¸·Î, Rapid Acceleration of Diagnostics Technology(RADx(R) Tech) Fetal Monitoring Challenge¸¦ ÅëÇØ Àü±¹ÀÇ ±â¼úÀÚ, °úÇÐÀÚ, ÀÓ»óÀÇ ±â¼úÀÚ, °úÇÐÀÚ, ÀÓ»óÀǵéÀÌ ¼±±¸ÀûÀÎ Á¢±Ù¹ýÀ» ¹ßÇ¥ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±¸»óÀº ÀӽŠÁß Á¤±âÀûÀÎ ¸ð´ÏÅ͸µÀÇ Á߿伺À» °­Á¶ÇÏ°í ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â¼úÀÇ Ã¤Åà Ȯ´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß ¹× Á¶±â °³ÀÔÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ÀӽŠ°á°ú¿Í ¿µ¾Æ °Ç°­À» °³¼±Çϱâ À§ÇÑ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¹Ý¿µÇÏ°í ÀÖ½À´Ï´Ù.

ÀüÀÚ ÅÂ¾Æ ¸ð´ÏÅ͸µ »ê¾÷Àº 2023-2032³â »çÀÌ¿¡ °ý¸ñÇÒ ¸¸ÇÑ ¹ßÀüÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº »êºÎÀΰú ÀÇ·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í Ãâ»ê Áß Å¾ÆÀÇ °Ç°­ »óÅ¿¡ ´ëÇÑ ½Ç½Ã°£ ÀλçÀÌÆ®À» Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ÀüÀÚ ÅÂ¾Æ ¸ð´ÏÅ͸µÀº žÆÀÇ ½É¹Ú¼ö¿Í Àڱà ¼öÃàÀ» Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇÏ¿© ÀáÀçÀû À§ÇèÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ žÆÀÇ ¾ÈÀüÀ» ¿ì¼±½ÃÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ÀÖ½À´Ï´Ù. »çÀü °³ÀÔÀ» ÃËÁøÇÏ°í ÀӽŠ°á°ú¸¦ °³¼±ÇÏ´Â ´É·ÂÀº Çö´ë »êºÎÀΰú ÀÇ·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶ÇÏ°í ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ¼ºÀå°ú äÅÃÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

Àü¹® Ŭ¸®´Ð ºÎ¹®Àº 2023-2032³â ÁÖ¸ñÇÒ ¸¸ÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À̵é Ŭ¸®´ÐÀº Á¾ÇÕÀûÀÎ »êÀü Áø·á¸¦ ¿ì¼±½ÃÇÏ°í ÀáÀçÀûÀÎ ÇÕº´ÁõÀ» Á¶±â¿¡ ¹ß°ßÇϱâ À§ÇØ Ã·´Ü ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â¼úÀ» äÅÃÇÏ°í ÀÖ½À´Ï´Ù. °íÀ§Çè ÀӽŰú Àü¹®ÀûÀÎ Ä¡·á¿¡ ÁßÁ¡À» µÐ À̵é Ŭ¸®´ÐÀº °í±Þ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ÀÇÁ¸ÇÏ°í ÀÖ½À´Ï´Ù. žÆÀÇ ¾È³çÀ» À§ÇÑ Àû±ØÀûÀÎ Á¶Ä¡¸¦ °­Á¶ÇÏ´Â ¸¸Å­ Àü¹®ÀûÀÎ ÅÂ¾Æ ¸ð´ÏÅ͸µ Àåºñ¿Í Àü¹® Áö½Ä¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå Àü¸Á°ú ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ´Â µ¥ ÀÖÀ¸¸ç, À̵é Ŭ¸®´ÐÀÇ ¿ªÇÒÀÌ ¸Å¿ì Áß¿äÇÏ´Ù´Â Á¡À» °­Á¶ÇÕ´Ï´Ù.

À¯·´ÀÇ ÅÂ¾Æ ¸ð´ÏÅ͸µ »ê¾÷Àº 2023-2032³â ´«¿¡ ¶ç´Â CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »ê¸ð¿Í žÆÀÇ °Ç°­¿¡ ´ëÇÑ È®°íÇÑ Çå½ÅÀ¸·Î À¯·´ÀÇ ÀÇ·á ½Ã½ºÅÛÀº ÷´Ü ¸ð´ÏÅ͸µ ±â¼úÀ» ¿ì¼±½ÃÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾ÈÀüÇÑ ÀӽŰú ÃÖÀûÀÇ Ãâ»ê °á°ú¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, À¯·´ Àü¿ª¿¡¼­ ³Î¸® ¹Þ¾Æµé¿©Áö°í ÀÖ½À´Ï´Ù. À¯·´ ±¹°¡µéÀÌ Á¾ÇÕÀûÀÎ »êÀü °ü¸®¸¦ °­Á¶ÇÔ¿¡ µû¶ó ÃÖ÷´Ü ÅÂ¾Æ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â Àû±ØÀûÀÎ ÇコÄÉ¾î °üÇàÀ» ÇâÇÑ Áý´ÜÀû ÃßÁø·ÂÀ» ¹Ý¿µÇϸç, À¯·´À» ÀӽŠ°ü¸®¿Í À¯¾ÆÀÇ º¹Áö¸¦ Çâ»ó½ÃÅ°´Â ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â¼ú ¹ßÀüÀÇ ÃÖÀü¼±¿¡ ¼­°Ô ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ¾÷°è ÀλçÀÌÆ®

  • COVID-19¿µÇ⠺м®
  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ±â¼ú »óȲ
  • ±ÔÁ¦ »óȲ
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ÀӽŠ°ü·Ã ÇÕº´ÁõÀÇ Áõ°¡
      • ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±âÀÇ ±â¼úÀû Áøº¸
      • ¸ðÀÚ °Ç°­ ÃËÁøÀ» ¸ñÀûÀ¸·Î ÇÑ Á¤ºÎ ±¸»óÀÇ Áõ°¡
      • ºñħ½ÀÀû µð¹ÙÀ̽ºÀÇ Ã¤Åà ±ÞÁõ
      • Á¶»ê °Ç¼öÀÇ Áõ°¡¿Í ºÒÀÓ Ä¡·áÀÇ Ã¤Åà Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ±â±âÀÇ °íºñ¿ë
      • Àç»ýÇ°ÀÇ °¡¿ë¼º
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
    • Koninklijke Philips N.V.
    • General Electric Company
    • Siemens AG
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°

  • ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
  • ÃÊÀ½ÆÄ Áø´Ü ±â±â
    • 2D ÃÊÀ½ÆÄ
    • 3D ¹× 4D ÃÊÀ½ÆÄ
    • µµÇ÷¯ ¿µ»ó
  • ÀüÀÚ ÅÂ¾Æ ¸ð´ÏÅ͸µ(EFM)
    • ¿ÜºÎ EFM
    • ³»ºÎ EFM
  • Àڱà ¼öÃà ¸ð´ÏÅÍ
  • ¾×¼¼¼­¸®¿Í ¼Ò¸ðÇ°
  • ±âŸ

Á¦6Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå Ã߻ꡤ¿¹Ãø : Æ÷Åͺô¸®Æ¼º°

  • ÁÖ¿ä µ¿Çâ : Æ÷Åͺô¸®Æ¼º°
  • ÈÞ´ë¿ë
  • ºñÈÞ´ë¿ë

Á¦7Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå Ã߻ꡤ¿¹Ãø : ¹æ½Äº°

  • ÁÖ¿ä µ¿Çâ : ¹æ½Äº°
  • ħ½ÀÀû
  • ºñħ½À¼º

Á¦8Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾ ¿ëµµº°
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ÅÂ¾Æ ¸ð´ÏÅ͸µ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ½ºÀ§½º
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • Æú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
    • Àεµ³×½Ã¾Æ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîƼ³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤

Á¦10Àå ±â¾÷ °³¿ä

  • Cardinal Health Inc.
  • MedGyn products, inc.
  • EDAN Instrument, Inc.
  • Natus Medical Incorporated.
  • Koninklijke Philips N.V.
  • General Electric Company
  • FUJIFILM Holdings Corporation
  • Siemens AG
  • Neoventa Medical AB
  • Huntleigh Healthcare(Arjo)
  • BD(Becton, Dickinson, and Company)
  • Medtronic plc
  • Spacelabs Healthcare
KSA 23.12.20

Global Fetal Monitoring Market will witness 6.7% CAGR between 2023 and 2032, propelled by governmental efforts to raise awareness and efficiency. Government organizations prioritize educating healthcare professionals and expecting them to understand the critical need for innovation in fetal monitoring.

For instance, in September 2023, The National Institutes of Health (NIH) initiated a $2 million prize competition to drive innovation in fetal diagnostic and monitoring technologies. This endeavor aims to enhance fetal health outcomes in low-resource settings. Through the Rapid Acceleration of Diagnostics Technology (RADx® Tech) Fetal Monitoring Challenge, engineers, scientists, and clinicians nationwide are invited to present their pioneering approaches. These initiatives emphasize the importance of regular monitoring during pregnancy, spurring increased adoption of fetal monitoring technologies. As awareness grows regarding the benefits of early detection and intervention, the fetal monitoring market demand experiences a surge, reflecting a proactive approach toward improving pregnancy outcomes and infant health.

The overall Fetal Monitoring Market is classified based on product, end-use, and region.

Electronic fetal monitoring industry will undergo significant development from 2023 to 2032. These advancements revolutionize obstetric care, providing real-time insights into fetal well-being during childbirth. Electronic fetal monitoring offers precise monitoring of fetal heart rate and uterine contractions, enhancing early detection of potential risks. As healthcare providers prioritize fetal safety, the demand surges for these innovative monitoring solutions. Their ability to facilitate proactive intervention and improve pregnancy outcomes underscores their pivotal role in modern obstetrics, driving the fetal monitoring market growth and adoption.

Specialty clinics segment will register a noteworthy CAGR from 2023 to 2032. These clinics prioritize comprehensive prenatal care, employing advanced fetal monitoring technologies for early detection of potential complications. With a focus on high-risk pregnancies and specialized care, these clinics rely on sophisticated monitoring systems. As they emphasize proactive measures for fetal well-being, the demand for specialized fetal monitoring equipment and expertise intensifies, underscoring the pivotal role of these clinics in driving the fetal monitoring market outlook and innovation.

Europe fetal monitoring industry will showcase a commendable CAGR from 2023 to 2032. With a steadfast commitment to maternal and fetal health, European healthcare systems prioritize advanced monitoring technologies. These innovations, vital in ensuring safe pregnancies and optimal birth outcomes, are widely embraced across the continent. As European nations emphasize comprehensive prenatal care, the demand for state-of-the-art fetal monitoring solutions surges. This reflects a collective drive towards proactive healthcare practices, positioning Europe at the forefront of advancing fetal monitoring technologies to enhance pregnancy care and infant well-being.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global fetal monitoring market 360 degree synopsis, 2018 - 2032
  • 2.2 Regional trends
  • 2.3 Product trends
  • 2.4 Portability trends
  • 2.5 Method trends
  • 2.6 End-use trends

Chapter 3 Fetal Monitoring Industry Insights

  • 3.1 COVID- 19 impact analysis
  • 3.2 Industry ecosystem analysis
  • 3.3 Technology landscape
  • 3.4 Regulatory landscape
  • 3.5 Industry impact forces
    • 3.5.1 Growth drivers
      • 3.5.1.1 Growing incidence of pregnancy-related complications
      • 3.5.1.2 Technological advancements in fetal monitoring devices
      • 3.5.1.3 Rising government initiatives aimed at promoting maternal and child health
      • 3.5.1.4 Surge in adoption of non-invasive devices
      • 3.5.1.5 Increasing number of preterm births and rising adoption of infertility treatment
    • 3.5.2 Industry pitfalls & challenges
      • 3.5.2.1 High cost of devices
      • 3.5.2.2 Availability of refurbished products
  • 3.6 Growth potential analysis
    • 3.6.1 By product
    • 3.6.2 By portability
    • 3.6.3 By method
    • 3.6.4 By end-use
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
    • 4.1.1 Koninklijke Philips N.V.
    • 4.1.2 General Electric Company
    • 4.1.3 Siemens AG
  • 4.2 Competitive analysis of major market players, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic outlook matrix, 2022

Chapter 5 Fetal Monitoring Market Estimates and Forecast, By Product (Revenue & Volume)

  • 5.1 Key trends, by product
  • 5.2 Ultrasound devices
    • 5.2.1 2D ultrasound
    • 5.2.2 3D and 4D ultrasound
    • 5.2.3 Doppler imaging
  • 5.3 Electronic fetal monitoring (EFM)
    • 5.3.1 External EFM
    • 5.3.2 Internal EFM
  • 5.4 Uterine contraction monitor
  • 5.5 Accessories and consumables
  • 5.6 Others

Chapter 6 Fetal Monitoring Market Estimates and Forecast, By Portability (Revenue)

  • 6.1 Key trends, by portability
  • 6.2 Portable
  • 6.3 Non-portable

Chapter 7 Fetal Monitoring Market Estimates and Forecast, By Method (Revenue)

  • 7.1 Key trends, by method
  • 7.2 Invasive
  • 7.3 Non-invasive

Chapter 8 Fetal Monitoring Market Estimates and Forecast, By End-use (Revenue)

  • 8.1 Key trends, by end-use
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Others

Chapter 9 Fetal Monitoring Market Estimates and Forecast, By Region (Revenue & Volume)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Switzerland
    • 9.3.7 The Netherlands
    • 9.3.8 Russia
    • 9.3.9 Poland
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Thailand
    • 9.4.7 Indonesia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Colombia
    • 9.5.5 Chile
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Israel

Chapter 10 Company Profiles

  • 10.1 Cardinal Health Inc.
  • 10.2 MedGyn products, inc.
  • 10.3 EDAN Instrument, Inc.
  • 10.4 Natus Medical Incorporated.
  • 10.5 Koninklijke Philips N.V.
  • 10.6 General Electric Company
  • 10.7 FUJIFILM Holdings Corporation
  • 10.8 Siemens AG
  • 10.9 Neoventa Medical AB
  • 10.10 Huntleigh Healthcare (Arjo)
  • 10.11 BD (Becton, Dickinson, and Company)
  • 10.12 Medtronic plc
  • 10.13 Spacelabs Healthcare
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦